Dätwyler (DAE) H1 2025 earnings summary

Executive summary

• Achieved strong momentum in H1 2025, with Healthcare and Food & Beverage driving growth, despite a 1.7% reported revenue decline due to FX effects; currency-adjusted revenue grew 1.3%.

• EBIT increased to CHF 68.9 million, with EBIT margin improving to 12.2% from 11.8% year-over-year, driven by product mix and cost management.

• Net result was CHF 37.9 million, slightly below prior year, representing 6.7% of revenues.

• ForwardNow transformation program launched, targeting over CHF 24 million annual profit improvements post-2027, with 20+ initiatives and organizational realignment.

• Operational improvements and cost adjustments implemented across all segments, with a focus on innovation and high-value products.

Financial highlights

• Net revenue CHF 563.0 million, down 1.7% year-over-year, but up 1.3% currency-adjusted.

• EBIT margin increased to 12.2% (+0.4pp vs. prior year); EBIT CHF 68.9 million (+2.1%).

• Gross profit margin improved to 23.1%, up 0.8 percentage points year-over-year.

• Free cash flow CHF 65.0 million; net cash from operating activities CHF 90.3 million.

• Capital expenditures CHF 25 million (4.5% of net revenues), up 23.9% year-over-year.

Outlook and guidance

• Expects continued Healthcare growth and robust Food & Beverage demand; Automotive and Industrial to remain subdued in Europe/US, with China strong for EVs.

• Reaffirms mid-term targets: high single-digit annual organic growth and EBIT margin above 17%.

• Innovation investments and ForwardNow program to support long-term growth.

• Order books confirm positive Healthcare trend; injectables expected to return to long-term growth.

• Industrial demand subdued, but selective recovery in connectivity and energy sectors.